calendar
56 catalysts · 16 phase 2 initiation · 13 phase 2 completion · 5 phase 1 completion · 4 phase 1 2 initiation · 3 phase 3 completion · 2 patent expiry
next 91 dayslessmore
MonWedFri
56 catalysts · 16 phase 2 initiation · 13 phase 2 completion · 5 phase 1 completion · 4 phase 1 2 initiation · 3 phase 3 completion · 2 patent expiry
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Solid Tumor
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Oncology. Indication: Metastatic Pancreatic Cancer, Pancreatic Cancer
Therapy area: Oncology. Indication: Nasopharyngeal Cancer